Outline
| Key Fields |
Infectious disease
|
| R&D phase |
Basic Study, Applied Study
|
| Contact |
-
Division for Promotion of Vaccine Research and Development, Department of Advanced Vaccine Research and Development
Japan Initiative for World-leading Vaccine Research and Development Centers
- E-mail: scarda-rdc"AT"amed.go.jp（Please replace "AT" with "@".）
|
Overview
Based on the Strategy for Strengthening the Vaccine Development and Production System and aiming for the achievement of Japanese-made vaccines, world-leading research and development centers (a flagship center, synergetic centers, support institutions) are set up. At these research centers, we strengthen and promote vaccine-related research aiming to achieve practical results during normal times.
Flagship center
In preparation for infectious disease emergencies, in order to exercise core functional roles in cutting-edge research during normal times, a flagship center was created that achieves flexible management in which independence and autonomy are secured, attracts researchers from around the world, and conducts hitherto unseen world-leading research and development.
Synergy centers
As institutions that take on research and development functions in an integrated manner with the flagship center, synergy centers conduct in particular research and development that makes the most of their various individual strengths, and form research centers that exert synergistic effects with other centers.
Support institutions
With regard to the flagship center and the synergy centers, the support institutions assume the role of support and common infrastructures for experimental animal breeding, human immunology analyses, genome analysis of illnesses associated with a higher risk of infectious diseases becoming critical, and other vital functions requisite for vaccine development.
R&D Projects
1 Flagship Center
| Project Name |
Representative Institution |
Principal Investigator |
Project Overview |
Web site |
| The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA) |
The University of Tokyo |
Yoshihiro KAWAOKA |
Document |
 |
2 Synergy Center
| Project Name |
Representative Institution |
Principal Investigator |
Project Overview |
Web site |
| Center for Advanced Modalities and DDS (CAMaD) |
Osaka University |
Shizuo AKIRA |
Document |
 |
| Synergy Institute fro Futuristic Mucoasl Vaccine Research and Development (cSIMVa) |
Chiba University |
Hiroshi KIYONO |
Document |
 |
| Vaccine Reaserch and Development Center (VRDC), DEJIMA Infectious Disease Research Alliance (DIDA) |
Nagasaki University |
Kouichi MORITA |
Document |
 |
| Institute for Vaccine Research and Development (IVRed) |
Hokkaido University |
Hirofumi SAWA |
Document |
 |
3-1-1 Small animal supply & animal model development center
| Project Name |
Representative Institution |
Principal Investigator |
Project Overview |
| Support organization for the development and supply of small laboratory animals useful for infectious disease research |
Central Institute for Experimental Medicine and Life Science (CIEM) |
Makoto SUEMATSU |
Document |
3-1-2 Non-human primate stupply and experiment center
| Project Name |
Representative Institution |
Principal Investigator |
Project Overview |
| Support organization for laboratory animal cynomolgus monkeys |
National Institutes of Biomedical Innovation, Health and Nutrition |
Yasuhiro YASUTOMI |
Document |
| Support Institute for Efficacy Evaluation of Vaccines Using a Nonhuman Primate Model |
Shiga University of Medical Science |
Yasushi ITOH |
Document |
3-2 Immunologycal analysis center
| Project Name |
Representative Institution |
Principal Investigator |
Project Overview |
| Immunomonitoring Center at Kyoto |
Kyoto University Immunomonitoring Center (KIC) |
Hideki UENO |
Document |
| Support institute for vaccine development by functional evaluation of human immune system through integration of genetic variations and multi-omics data |
RIKEN Center for Integrative Medical Science |
Kazuhiko YAMAMOTO |
Document |
3-3 Genome data analysis center
| Project Name |
Representative Institution |
Principal Investigator |
Project Overview |
| Exploration of risk factors involved in the severity of emerging infectious disease by establishing a surveillance system and omics analysis based on a large-scale disease cohort and academia collaboration |
The University of Tokyo |
Yuji YAMANASHI |
Document |
Evaluation and Management Framework
Program Supervisor (PS)
- HAMAGUCHI Michinari, M.D., Ph.D., Director General, Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA)
Program Officers (POs)
- KARASUYAMA Hajime, M.D., Ph.D., Professor at Institute of Integrated Research, Institute of Science Tokyo
- KOKUBO Toshio, Ph.D., High Class Research Administrator, International Institute for Integrative Sleep Medicine, University of Tsukuba
- SUGANO Sumio, M.D., Ph.D., Representative Director, Kashiwa-no-ha Omics Gate Association
- HASEGAWA Yoshinori, M.D., Ph.D., Emeritus Director, National Hospital Organization, Nagoya Medical Center
- YAMASHITA Makoto, Ph.D., Visiting Professor, Aichi Medical University
